Cardio Diagnostics Holdings (NASDAQ: CDIO) reported Q2 2023 earnings per share (EPS) of -$0.39, up 143.75% year over year. Total Cardio Diagnostics Holdings earnings for the quarter were -$4.02 million. In the same quarter last year, Cardio Diagnostics Holdings's earnings per share (EPS) was -$0.16.
As of Q3 2023, Cardio Diagnostics Holdings's earnings has grown year over year. Cardio Diagnostics Holdings's earnings in the past year totalled -$8.58 million.
What was CDIO's revenue last quarter?
Cardio Diagnostics Holdings (NASDAQ: CDIO) reported Q2 2023 revenue of $1.73 thousand up Infinity% year over year. In the same quarter last year, Cardio Diagnostics Holdings's revenue was $0.00.
What was CDIO's revenue growth in the past year?
As of Q3 2023, Cardio Diagnostics Holdings's revenue has grown 196.89% year over year. This is 96.15 percentage points higher than the US Biotechnology industry revenue growth rate of 100.74%. Cardio Diagnostics Holdings's revenue in the past year totalled $2.68 thousand.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.